News — AI supercycle headlines

Zacks19h agoneutral

Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?

HIMS first-quarter 2026 results are likely to benefit from Labs and branded weight loss medications even as higher costs and GLP-1 scrutiny linger.

HIMS VEEV

Simply Wall St.21h agoneutral

Is It Time To Reconsider Veeva Systems (VEEV) After Recent Share Price Weakness

Investors may be wondering whether Veeva Systems at about US$168.25 is starting to look interesting, or if the stock still carries too much optimism in its price. Over the last week the share price has moved by 7.9%, compared with a 2.5% decline over 30 days and deeper returns of 23.3% year to date and 29.8% over the past year. Recent coverage has focused on Veeva Systems as a key healthcare software provider, with attention on how its role in life sciences workflows might affect sentiment...

Zacks23h agoneutral

Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know

Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

VEEV

Zacks2d agoneutral

Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $167.29, denoting a -2.28% move from the preceding trading day.

VEEV

Zacks4d agoneutral

Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell

Veeva Systems, Doximity and Omnicell ride rising AI-driven healthcare demand as medical info systems expand despite cybersecurity and regulatory risks.

VEEV

StockStory4d agoneutral

3 Profitable Stocks to Research Further

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

VEEV

Zacks4d agoneutral

3 Medical Info Systems Stocks Riding the GenAI Wave in a Tough Market

Doximity, Veeva and Omnicell ride surging GenAI adoption in healthcare, tapping digital demand despite market pressure and rising cybersecurity risks.

VEEV

Zacks4d agoneutral

Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet

According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

VEEV

Simply Wall St.5d agoneutral

Veeva Systems (VEEV) Is Up 6.9% After S&P 500 Addition and GC Transition News

In April 2026, Veeva Systems Inc. announced that long-time Senior Vice President and General Counsel Josh Faddis will retire on November 1, 2026, transitioning to a part-time advisory role thereafter. Around the same time, Veeva revealed it will be added to the S&P 500 Index, a milestone that often broadens a company’s investor base and enhances trading liquidity. We’ll now explore how Veeva’s S&P 500 inclusion may influence its investment narrative built around AI integration and...

VEEV ^GSPC